ALERT!
This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
Daniel Engelman
Daniel T. Engelman, M.D.
Background
Dr. Engelman is the Medical Director of the Heart, Vascular and Critical Care Units at Baystate Medical you Center. He is a Professor of Surgery at The University of Massachusetts-Baystate, and Tufts University School of Medicine. He started the Enhanced Recovery After Cardiac Surgery (ERAS® Cardiac) Collaborative to nationally standardize best practices. He is led a group of international experts to publish the first consensus guidelines for best practices in enhanced recovery following cardiac surgery. This was recently published in JAMA Surgery. It has been downloaded over 90,000 times and is the number one most viewed publication ever from this prestigious journal in the first month. He has organized symposium at multiple international meetings on the topic. He has lead multiple symposium at the last three STS, AATS, EACTS, and the STS/Critical Care annual meetings on ERAS. He is a co-founder of HealthChain Solutions Inc. This company was established to develop B2B blockchain platforms and applications focusing on the Life Sciences industry. He is also the President of the Massachusetts Society of Thoracic Surgeons and also serves on multiple Statewide Oversight committees. Dr. Engelman participates on five national workforces for the Society of Thoracic Surgeons and the American Association of Thoracic Surgery. He writes board questions for Cardiac Surgical Certification. He was the Past President of the 21st Century Cardiothoracic Surgical Society. He also serves on the Board of Directors of the Baycare PPO and ACO and is Vice President of the local Independent Physician Organization. Dr. Engelman is the principal investigator on multiple research projects, has published over 70 peer-reviewed publications, and participates on two international taskforces (ADQI and KDIGO) standardizing approaches for the prevention of postoperative acute kidney injury. He travels extensively lecturing on advances in critical care medicine, healthcare informatics and finance, multimodal analgesia, and enhanced recovery after cardiac surgery. In 2016 Dr. Engelman was named the National ACS/STS Health Policy Scholar. He is a graduate of the Executive Leadership Program in Health Policy and Management at The Heller School of Brandeis University. He was a Research Fellow at the University of Connecticut School of Medicine. He completed his Cardiothoracic Surgical training at Brigham & Women's Hospital, Harvard University, in Boston. He received his B.A. with honors from the University of Pennsylvania and M.D. from the New York University School of Medicine.
Other Interests
I am a Cardiac Surgeon with a special interest in critical care medicine, healthcare economics, outcomes, financial risk arrangements, and new technology. I am actively promoting the leadership role of Cardiothoracic Surgeons on a multidisciplinary critical care team. I have founded the Enhanced Recovery After Cardiac Surgery Society (www.erascardiac.org). The goal is to disseminate best practices in cost-effective methods to improve patients' recoery after cardiac surgery.
Research
1. Engelman DT, Thayer J, DeRossi J, Scheinerman J, Brown L. Pregnancy related coronary artery dissection: a case report and collective review. Conn Med 1993;57:135-139. 2. Engelman DT, Watanabe M, Engelman RM, Rousou JA, Flack JE, Deaton DW, Kisin E, Kagan V, Das DK. Hypoxic preconditioning preserves antioxidant reserve and prevents calcium overload in the ischemic/reperfused working rat heart. Surg Forum 1994;45:209-212. 3. Tosaki A, Engelman DT, Pali T, Engelman RM, Droy-Lefaix MT. Ginkgo biloba extract (Egb 761) improves postischemic function in isolated preconditioned working rat hearts. Coron Artery Dis 1994;5:443-450. 4. Moraru II, Engelman DT, Engelman RM, Rousou JA, Flack JE, Deaton DW, Das DK. Myocardial ischemia triggers rapid expression of mitochondrial genes. Surg Forum 1994;45:315-317. 5. Engelman DT, Watanabe M, Engelman RM, Rousou JA, Kisin E, Kagan VE, Maulik N, Das DK. Hypoxic preconditioning preserves antioxidant reserve in the working rat heart. Cardiovasc Res 1995;29:133-40. 6. Engelman DT, Chen C, Watanabe M, Kulshrestha P, Das DK, Rousou JA, Flack JE, Deaton DW,Engelman RM. Hypoxic preconditioning enhances functional recovery after prolonged cardioplegic arrest. Ann Thorac Surg 995;59:428-32. 7. Maulik N, Watanabe M, Engelman DT, Engelman RM, Das DK. Oxidative stress adaptation improves postischemic ventricular recovery. Mol Cell Biochem 1995;144:67-74. 8. Tosaki A, Behjet NS, Engelman DT, Engelman RM, Das DK. Alpha-1 adrenergic receptor agonist-induced preconditioning in isolated working rat hearts. J Pharmacol Exp Ther 1995;273:689-94. 9. Engelman DT. New frontiers in myocardial protection: harnessing the heart’s endogenous protective systems. Conn Med 1995;59:401-5.10. Engelman DT, Watanabe M, Maulik N, Engelman RM, Rousou JA, Flack JE, Deaton DW, Das DK. L- arginine reduces the endothelial inflammatory response and myocardial stunning following ischemia/reperfusion. Surg Forum 1995;46:233-236.11. Engelman DT, Watanabe M, Engelman RM, Rousou JA, Flack JE, Deaton DW, Das DK. Constitutive nitric oxide release is impaired after ischemia and reperfusion. J Thorac Cardiovasc Surg 1995;110:1047-53. 12. Maulik N, Watanabe M, Engelman DT, Engelman RM, Kagan VE, Kisin E, Tyurin V, Cordis GA, Das DK. Myocardial adaptation to ischemia by oxidative stress induced by endotoxin. Am J Physiol 1995;269:C907- 916. 13. Engelman DT, Chen C, Watanabe M, Engelman RM, Rousou JA, Flack JE, Deaton DW, Maulik N, Das DK. Improved four and six hour myocardial preservation by hypoxic preconditioning. Circulation 1995;92:II-417- 22. 14. Engelman DT, Watanabe M, Maulik N, Cordis GA, Engelman RM, Rousou JA, Flack JE, Deaton DW, Das DK. L-arginine reduces the endothelial inflammation and myocardial stunning following ischemia/reperfusion. Ann Thorac Surg 1995;60:1275-81. 15. Maulik N, Engelman DT, Watanabe M, Engelman RM, Maulik G, Cordis GA, Das DK. Nitric oxide signaling in ischemic heart. Cardiovasc Res 1995;30:593-601. 16. Tosaki A, Engelman DT, Engelman RM, Das DK. Diabetes and ATP-sensitive potassium channel openers and blockers in isolated ischemic/reperfused hearts. J Pharmacol Exp Ther 1995;275:1115-23. 17. Engelman DT, Gabram SGA, Allen L, Ens GE, Jacobs LM. Hypercoagulability following multiple trauma.World J Surg 1996;20:5-10. 18. Maulik N, Engelman DT, Watanabe M, Engelman RM, Das DK. Nitric oxide: a retrograde messenger for carbon monoxide signaling in ischemic heart. Mol Cell Biochem 1996;157:75-86. 19. Tosaki A, Engelman DT, Engelman RM, Das DK. The evolution of diabetic response to ischemia/reperfusion and preconditioning in isolated working rat heart. Cardiovasc Res 1996;31:526-36. 20. Maulik N, Engelman DT, Watanabe M, Engelman RM, Rousou JA, Flack JE, Deaton DW, Gorbunov NV, Elsayed NM, Kagan VE, Das DK. Nitric oxide/carbon monoxide: A molecular switch for myocardial preservation during ischemia. Circulation 1996;94:398-406. 21. Engelman DT, Watanabe M, Maulik N, Engelman RM, Rousou JA, Flack JE, Deaton DW, Das DK. Critical timing of nitric oxide supplementation in cardioplegic arrest and reperfusion. Circulation 1996;94;407-411. 22. Maulik N, Watanabe M, Engelman DT, Engelman RM, Rousou JA, Flack JE, Deaton DW, Das DK. Nitric oxide attenuates myocardial ischemia-reperfusion injury by functioning as synchronizing messenger with carbon monoxide and intracellular antioxidant. Surg Forum 1996;47:230-233. 23. Engelman RM, Engelman DT, Rousou JA, Flack JE, Deaton DW, Tighe D, Rifkin R, Gregory CA. The influence of myocardial temperature on stunning following coronary revascularization. Ann NY Acad Sci 1996;793:319-327. 24. Yoshida T, Watanabe M, Engelman DT, Engelman RM, Schley J, Maulik N, Ho Y-S, Oberley TD, Das DK. Transgenic mice overexpressing glutathione peroxidase are resistant to myocardial ischemia reperfusion. J Mol Cell Cardiol 1996;28:1759-67. 25. Tosaki A, Maulik N, Engelman DT, Engelman RM, Das DK. The role of protein kinase C in ischemic/reperfused preconditioned isolated rat hearts. J Cardiovasc pharmacol 1996;28:723-31. 26. Engelman DT, Adams DH, Byrne JG, Aranki SF, Collins JJ, Couper GS, Allred EN, Cohn LH, Rizzo RJ. Impact of body mass index and albumin on cardiac surgery morbidity and mortality. J Thorac Cardiovasc Surg 1999;118:866-73. 27. Engelman DT, Cohn LH, Rizzo RJ. Incidence and predictors of TIA’s and strokes following coronary artery bypass grafting: report and collective review. Heart Surg Forum 1999;Vol. 2,(3):242-5. 28. Munshi IA, Engelman DT. Thoracic aortic transection secondary to blunt trauma. J Trauma 2000;Vol.48,(5):985. 29. Yoshida T, Engelman RM, Engelman DT, Rousou JA, Maulik N, Sato M, Elliot GT, Das DK. Preconditioning of swine heart with monophosphoryl lipid A improves myocardial preservation. Ann Thorac Surg 2000;70:895-900. 30. Klein S, Munshi IA, Engelman DT, Ganai S, Kulshrestha P. Inominate artery transaction secondary to blunt trauma. J Trauma 2003;54:202. 31. Alameddine AK, Alimov VK, Engelman RM, Rousou JA, Flack JE 3rd, Deaton DW, Engelman DT. Anatomic variations of the radial artery: significance when harvesting for coronary artery bypass grafting. J Thorac Cardiovasc Surg. 2004 Jun;127(6):1825-7. 32. Alameddine AK, Alimov VK, Engelman DT. Statistical methodology for analysis of endoscopic versus open saphenous vein harvest techniques. Ann Thorac Surg. 2010 Nov;90(5):1743-4; author reply 1744. 33. Alameddine AK, Alimov VK, Engelman DT. Patent foramen ovale and embolic stroke "en flagrant délit".Am J Med Sci. 2012 Apr;343(4):342. 34. Alameddine AK, Engelman DT. The rationale and design of the minocycline plus amiodarone versus amiodarone alone (MINAA) trial for the prevention of atrial fibrillation after cardiac surgery. Worldworld J Cardiovasc Dis. 2012;2:2069-76. 35. Engelman DT, Higgins TL, Talati R, Grimsman J. Maintaining situational awareness cardiac intensive care unit. J Thorac Cardiovasc Surg. 2014 Mar;147(3):1105-6. 36. Engelman RM, Engelman DT. Strategies to Minimize Stroke in Adult Cardiac Surgery. Sem Thorac Surg.2015 27:24-29. 37. Lotfi AS, Eftekhari H, Atreya AR, Kashikar A, Sivalingam SK, Giannoni M, Visintainer P, Engelman D. Randomized Controlled Trial of Remote Ischemic Preconditioning and Atrial Fibrillation in Patients Undergoing Cardiac Surgery. World J Cardiol 2016 October 26; 8(10): 615-622. 38. Stone GW, Sabik JF, Simonton CA, et al. Everolimus-Eluting Stents or Bypass Surgery for Left Main Coronary Artery Disease. N Engl J Med. 2016 Dec 8;375(23):2223-2235. 39. Engelman DT, Surgical Economics: MACRA, MIPS, & Bundles. Lessons Learned in the First Three Years of a CABG Alternative Payment Model, Featured Article, J Thorac Cardiovasc Surg. 2017 Feb;153(2):381- 384. doi: 10.1016/j.jtcvs.2016.09.052. 40. Engelman DT. Value-based health care: How to succeed in a bundled care APM. Bull Am Coll Surg. Mar 2017: Vol 102 3. 41. Engelman D, Benjamin EM. Physician Engagement: The ‘Secret Sauce’ to Success in Bundled Healthcare. Am J Med Qual. 2017 Apr 1:1062860617703730. doi: 10.1177/1062860617703730. 42. Engelman DT, Boyle EM, Benjamin EM. Addressing the Imperative to Evolve the Hospital New Product Value Analysis Process. J Thorac Cardiovasc Surg. February 2018. Vol 155, Issue 2, 682–685. 43. Engelman DT, Jaime Hernandez-Montfort. Is it Time to Mandate Regional Acute Mechanical Circulatory Support/ECMO Centers? J Thorac Cardiovasc Surg. April 2018. Vol 155, Issue 4, 1630–1631. 44. Engelman DT, Kellum JA. Should Urinary Biomarkers be a Standard Component of Evaluation After Cardiac Surgery? J Thorac Cardiovasc Surg, 2018-06-01, Volume 155, Issue 6, Pages 2453-2454. 45. Engelman DT, Steingrub J. Is VA-ECMO the First-line Therapy for Massive Pulmonary Embolus with End-Organ Dysfunction? J Thorac Cardiovasc Surg. Volume 156: Issue 2, p 682-3. 46. Nadim NK, Forni LG, Bihorac A, Engelman DT, et al. Cardiac and Vascular Surgery–Associated Acute Kidney Injury: The 20th International Consensus Conference of the ADQI (Acute Disease Quality Initiative) Group. J Am Heart Ass. 2018;7:e008834. DOI: 10.1161/JAHA.118.008834. 47. Engelman DT, Kellum JA. The difficulty of predicting postoperative acute kidney injury from preoperative clinical data. J Thorac Cardiovasc Surg. doi.org/10.1016/j. J Thorac Cardiovasc Surg. Sept 2018. Vol 145, 3, p. 1124. 48. Katsikeris F, Lau E, Engelman DT, et. al. Personalizing Care in Cardiogenic Shock: Searching for a Common Hemodynamic Language. Heart & Lung. J of Acute and Crit Care. Heart Lung. 2019 Vol 48, Issue 1, p. 73-75. 49. Engelman DT, Germain MJ. Looking to Prevent Acute Kidney Injury After Cardiac Surgery? Just Check the Urine. J Thorac Cardiovasc Surg. 2019, 157:4, p.1554-5. 50. Williams, JB, McConnell G, Engelman DT, et al. One-Year Results from the First US-based Enhanced Recovery after Cardiac Surgery (ERAS Cardiac) Program. J Thorac Cardiovasc Surg. May 2019, Volume 157, Issue 5, p. 1881-8. 51. S. Chatterjee, JG Shake, RC Arora, DT Engelman, et. Al. Handoffs from the Operating Room to the Intensive Care Unit after Cardiothoracic Surgery: From the Society of Thoracic Surgeons Workforce on Critical Care. Ann Thorac Surg. 2019 Feb;107(2):619-630. 52. Shahian, D.M., Torchiana DF, Engelman DT et al., Mandatory public reporting of cardiac surgery outcomes: The 2003 to 2014 Massachusetts experience. J Thorac Cardiovasc Surg. 2018 Dec 31. pii: S0022-5223(18)33516-5. 53. Engelman DT, Deaton, DW. With a median survival of only 2 to 3 years, should dialysis patients more than 50 years old exclusively have transcatheter valves? J Thorac Cardiovasc Surg. 2018 Nov 2. pii: S0022-5223(18)32876-9. 54. Greenhouse DG, Schwann TA, Engelman DT. Preoperative Anemic Patients Have PoorOutcomes; How Can We Optimize These Patients Prior to Surgery? Semin Thorac Cardiovasc Surg. 2019 Summer;31(2):164-165. 55. Zarbock A, Engelman DT. Keep Your Ion the Urine – a new way to predict postoperative acute kidney injury? J Thorac Cardiovasc Surg. 2019 Mar 15. pii: S0022-5223(19)30589-6. 56. Engelman DT, Ben Ali W, Williams JB, et al., Guidelines for Perioperative Care in Cardiac Surgery: Enhanced Recovery After Surgery Society Recommendations. JAMA Surg. 2019;154(8):755-766. doi:10.1001/jamasurg.2019.1153 57. Lobdell KW, Engelman DT. Cardiac Surgery, Nutrition, and Recovery: First Define the Problem. J Thorac Cardiovasc Surg. 2019 Apr 4. pii: S0022-5223(19)30743-3. 58. Zarbock A, Engelman DT. Should goal-directed fluid therapy be used in every cardiac surgery patient to prevent acute kidney injury? JTCVS, in press. https://doi.org/10.1016/j.jtcvs.2019.04.044 59. Engelman DT, Arora RC, Boyle, Jr. EM, Lobdell KW. Enhanced Recovery After Cardiac Surgery Part I: Background and Preoperative Recommendations. CTSnet. May 2019. doi:10.25373/ctsnet.8090819 60. Guzzi LM, Bergler T, Engelman DT, et al. Clinical Use of [TIMP-2]•[IGFBP7] Biomarker Testing to Assess Risk of Acute Kidney Injury in Critical Care: Guidance from an Expert Panel. Crit Care. 2019 Jun 20;23(1):225. doi: 10.1186/s13054-019-2504-8. 61. Engelman DT. Urinary Biomarkers to Reduce Postoperative Acute Kidney Injury. Clin Surg. 2019; 4: 2284. 62. Engelman DT, Arora RC, Grant M, Lobdell KW, Perrault LP. Enhanced Recovery After Surgery Cardiac Panel Part II: Intraoperative and Postoperative. CTSnet Roundtable. June 2019. doi:10.25373/ctsnet.8224547. 63. Arora RD, Chatterjee S, Shake JG, Engelman DT, et al. Survey of Contemporary Cardiac Surgery ICU Models in the United States. Ann Thorac Surg, in press. https://doi.org/10.1016/j.athoracsur.2019.06.077 64. Engelman DT, Perrault L, Gerdisch M, Grant M, Williams J. ERAS Guidelines for Perioperative Care in Cardiac Surgery. CTSnet Roundtable. July 2019. doi:10.25373/ctsnet.8321060. 65. Engelman DT, Crisafi C, Germain M, et al. Utilizing Urinary Biomarkers to Reduce Acute Kidney Injury Following Cardiac Surgery, J Thorac Cardiovasc Surg, in press. 66. Fletcher, N, Engelman DT. Postoperative care: Who should Care for our Patients after Surgery, Anesthesia/British J of Surg, Joint Issue Special Supplement. Jan 2020. In press. Books & Chapters: 1. Higgins TL, Engelman DT. Chapter 39. Postoperative Respiratory Care in Kaplan "Cardiac Anesthesia" 7th edition. 2017. 2. Kaplan JA, Cronin B, Maus T, Engelman DT, Kaplan’s Essentials of Cardiac Anesthesia for Cardiac Surgery. Postoperative Respiratory Care, Chapter 29, p.742-57. 2017. 3. Gregory AJ, Engelman DT, Williams JB, Arora RC, Boyle EM. Enhanced Recovery After Surgery - A Complete Guide to Optimizing Outcomes, Section VIII, Cardiac Surgery ERAS, Springer Publishing, in press.
Additional Educational Information
University of Pennsylvania (B.A. May 1986)New York University School of Medicine (M.D. 1990)University of Connecticut Integrated General Surgery Residency (1990-1993; 1995-1997)University of Connecticut Cardiac Surgical Research Fellowship (1993-1995)Brigham and Women's Hospital Cardiothoracic Residency (1997-1999)
Printer-friendlyContent Published on CTSNet
Practice Areas
- Cardiac
- Critical Care